Abstract:Hydroxyapatite (HAp) is a bioceramic naturally present in human bones and teeth, prized for its exceptional biocompatibility, bioactivity, and capacity for osteointegration, rendering it a viable candidate for biomedical applications as a drug delivery system. Nevertheless, HAp possesses limited antibacterial properties. Thus, the present study focuses on synthesizing HAp/alginate/copper oxide (HAp/Alg/CuO) composite to augment these attributes. An environmentally friendly synthesis approach is explored to create the HAp/Alg/CuO composite. Polyscias scutellaria leaf extract is anticipated to function as a capping agent, facilitating control over the composite’s morphology. In addition, residual bamboo clam shells serve as the precursor material for HAp fabrication. The composites prepared were analyzed by a series of characterization techniques such as X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and scanning electron microscopy-energy dispersive spectroscopy (SEM-EDS). XRD analysis revealed the formation of HAp/Alg/CuO composites exhibiting a hexagonal structure consistent with the ICSD (The inorganic Crystal Structure Database) #157481 standard. The crystallite size was obtained at 30.00, 33.35, 24.14, and 26.84 nm for HAp/Alg/CuO-1, HAp/Alg/CuO-2, HAp/Alg/CuO-3, and HAp/Alg/CuO-4, respectively. FTIR analysis confirmed the presence of the hydroxyl, phosphate, carboxylic, and metal-oxide (Cu–O) bonds. SEM images revealed irregularly shaped, agglomerated particles with an average particle size of 0.416 μm. EDS spectra exhibited calcium, carbon, phosphorus, and oxygen elements. Clindamycin-loaded HAp/Alg/CuO composites were assessed for their antibacterial efficacy against Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli bacteria. The inhibition zones observed suggest that clindamycin-loaded HAp/Alg/CuO composites hold promise as drug delivery vehicles. Further investigation and development of these composites are warranted, with potential applications in treating specific ailments attributed to S. aureus and E. coli infections, such as osteomyelitis.

Preparation of ciprofloxacin-loaded oyster shell derived hydroxyapatite composite film for biomedical applications

A Chitosan/gelatin/aldehyde Hyaluronic Acid Hydrogel Coating Releasing Calcium Ions and Vancomycin in Ph Response to Prevent the Formation of Bacterial Biofilm

Organic-inorganic composite of polypropylene fumarate and nanohydroxyapatite as carrier of antibiotics for the treatment of bone infections

Design of antibacterial apatitic composite cement loaded with Ciprofloxacin: Investigations on the physicochemical Properties, release Kinetics, and antibacterial activity

Synthesis and characterization of hydroxyapatite-ciprofloxacin delivery systems by precipitation and spray drying technique

Ciprofloxacin-loaded chitosan-based nanocomposite hydrogel containing silica nanoparticles as a scaffold for bone tissue engineering application

Green precipitation method using Polyscias scutellaria extract in the synthesis of hydroxyapatite/alginate/copper (II) oxide composites as a drug carrier

Fabrication of Biologically Active Fish Bone Derived Hydroxyapatite and Montmorillonite Blended Sodium Alginate Composite for In-Vitro Drug Delivery Studies

Mussel shell-derived biogenic hydroxyapatite as reinforcement on chitosan-loaded gentamicin composite for antibacterial activity and bone regeneration

Silver Nanoparticle-Incorporated Hydroxyapatite-Chitosan-PVP-Based Scaffold for Bone Tissue Engineering: Physicochemical Characterization, Antibacterial Activity, and In Vitro Ceftriaxone Release Study

Synthesis and Characterization of Hydroxyapatite Composite from Cuttlebone (Sepia sp.) with Chitosan via In Situ as Antibacterial

Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial

Biodegradable chitosan-based composites with dual functions acting as the bone scaffold and the inflammation inhibitor in the treatment of bone defects

Physicochemical and biological behaviour of biogenic derived hydroxyapatite and carboxymethyl cellulose/sodium alginate biocomposite coating on Ti6Al4V alloy for biomedical applications

Composite Drug Delivery System Based on Amorphous Calcium Phosphate–Chitosan: An Efficient Antimicrobial Platform for Extended Release of Tetracycline

Surface configuration of microarc oxidized Ti with regionally loaded chitosan hydrogel containing ciprofloxacin for improving biological performance

Injectable polyelectrolyte complex-nascent HAP biodegradable antibiotic delivery system for the treatment of osteomyelitis

Polycaprolactone Microsphere‐Encapsulated Fluconazole‐Loaded Zinc Oxide and Hydroxyapatite Nanocomposites for Enhanced Biological Performance

Antibacterial nano-biocomposite scaffolds of Chitosan, Carboxymethyl Cellulose and Zn & Fe integrated Hydroxyapatite (Chitosan-CMC-FZO@HAp) for bone tissue engineering

TiO2 doped chitosan/poly (vinyl alcohol) nanocomposite film with enhanced mechanical properties for application in bone tissue regeneration

Fabrication, Characterization and Drug Release of Ciprofloxacin Loaded Porous Polyvinyl Alcohol/Bioactive Glass Scaffold for Controlled Drug Delivery